966 related articles for article (PubMed ID: 31341421)
21. Effect of Fusobacterium nucleatum on the T and B cell responses to Porphyromonas gingivalis in a mouse model.
Gemmell E; Bird PS; Carter CL; Drysdale KE; Seymour GJ
Clin Exp Immunol; 2002 May; 128(2):238-44. PubMed ID: 11985513
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the expression of NLRP3 and AIM2 in periapical lesions with apical periodontitis and microbial analysis outside the apical segment of teeth.
Ran S; Liu B; Gu S; Sun Z; Liang J
Arch Oral Biol; 2017 Jun; 78():39-47. PubMed ID: 28193569
[TBL] [Abstract][Full Text] [Related]
23. Differential involvement of the canonical and noncanonical inflammasomes in the immune response against infection by the periodontal bacteria
De Andrade KQ; Almeida-da-Silva CLC; Ojcius DM; Coutinho-Silva R
Curr Res Microb Sci; 2021 Dec; 2():100023. PubMed ID: 34841314
[TBL] [Abstract][Full Text] [Related]
24. NOX1/2 activation in human gingival fibroblasts by Fusobacterium nucleatum facilitates attachment of Porphyromonas gingivalis.
Ahn SH; Song JE; Kim S; Cho SH; Lim YK; Kook JK; Kook MS; Lee TH
Arch Microbiol; 2016 Aug; 198(6):573-83. PubMed ID: 27071620
[TBL] [Abstract][Full Text] [Related]
25. Vaccination of mice with Porphyromonas gingivalis or Fusobacterium nucleatum modulates the inflammatory response, but fails to prevent experimental periodontitis.
Polak D; Wilensky A; Shapira L; Weiss EI; Houri-Haddad Y
J Clin Periodontol; 2010 Sep; 37(9):812-7. PubMed ID: 20670341
[TBL] [Abstract][Full Text] [Related]
26. Serum antibodies of periodontitis patients compared to the lipopolysaccharides of Porphyromonas gingivalis and Fusobacterium nucleatum.
Onoue S; Imai T; Kumada H; Umemoto T; Kaca W; Isshiki Y; Kaneko A; Kawahara K
Microbiol Immunol; 2003; 47(1):51-5. PubMed ID: 12636253
[TBL] [Abstract][Full Text] [Related]
27. Enhanced attachment of Porphyromonas gingivalis to human fibroblasts mediated by Fusobacterium nucleatum.
Metzger Z; Blasbalg J; Dotan M; Weiss EI
J Endod; 2009 Jan; 35(1):82-5. PubMed ID: 19084131
[TBL] [Abstract][Full Text] [Related]
28. Regulation of the NLRP3 inflammasome in Porphyromonas gingivalis-accelerated periodontal disease.
Yamaguchi Y; Kurita-Ochiai T; Kobayashi R; Suzuki T; Ando T
Inflamm Res; 2017 Jan; 66(1):59-65. PubMed ID: 27665233
[TBL] [Abstract][Full Text] [Related]
29.
Cheng R; Liu W; Zhang R; Feng Y; Bhowmick NA; Hu T
Front Cell Infect Microbiol; 2017; 7():474. PubMed ID: 29184853
[TBL] [Abstract][Full Text] [Related]
30. Inflammasome dysregulation in human gingival fibroblasts in response to periodontal pathogens.
Aral K; Milward MR; Cooper PR
Oral Dis; 2022 Jan; 28(1):216-224. PubMed ID: 33368813
[TBL] [Abstract][Full Text] [Related]
31. Host modulation of tissue destruction caused by periodontopathogens: effects on a mixed microbial infection composed of Porphyromonas gingivalis and Fusobacterium nucleatum.
Ebersole JL; Feuille F; Kesavalu L; Holt SC
Microb Pathog; 1997 Jul; 23(1):23-32. PubMed ID: 9250777
[TBL] [Abstract][Full Text] [Related]
32. The anti-periodontitis action of metformin via targeting NLRP3 inflammasome.
Tan Y; Chen J; Jiang Y; Chen X; Li J; Chen B; Gao J
Arch Oral Biol; 2020 Jun; 114():104692. PubMed ID: 32305805
[TBL] [Abstract][Full Text] [Related]
33. Porphyromonas gingivalis Capsule-Mediated Coaggregation as a Virulence Factor in Mixed Infection With Fusobacterium nucleatum.
Polak D; Ferdman O; Houri-Haddad Y
J Periodontol; 2017 May; 88(5):502-510. PubMed ID: 27885964
[TBL] [Abstract][Full Text] [Related]
34. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
Han X; LaRosa KB; Kawai T; Taubman MA
Vaccine; 2014 Jan; 32(2):297-303. PubMed ID: 24051159
[TBL] [Abstract][Full Text] [Related]
35. Biochemical characterization of a recombinant Lactobacillus acidophilus strain expressing exogenous FomA protein.
Ma L; Li F; Zhang X; Feng X
Arch Oral Biol; 2018 Aug; 92():25-31. PubMed ID: 29747062
[TBL] [Abstract][Full Text] [Related]
36. Doxycycline inhibits NAcht Leucine-rich repeat Protein 3 inflammasome activation and interleukin-1β production induced by Porphyromonas gingivalis-lipopolysaccharide and adenosine triphosphate in human gingival fibroblasts.
Xu S; Zhou Q; Fan C; Zhao H; Wang Y; Qiu X; Yang K; Ji Q
Arch Oral Biol; 2019 Nov; 107():104514. PubMed ID: 31394382
[TBL] [Abstract][Full Text] [Related]
37. NLRX1 modulates differentially NLRP3 inflammasome activation and NF-κB signaling during Fusobacterium nucleatum infection.
Hung SC; Huang PR; Almeida-da-Silva CLC; Atanasova KR; Yilmaz O; Ojcius DM
Microbes Infect; 2018; 20(9-10):615-625. PubMed ID: 29024797
[TBL] [Abstract][Full Text] [Related]
38. A built-in adjuvant-engineered mucosal vaccine against dysbiotic periodontal diseases.
Puth S; Hong SH; Na HS; Lee HH; Lee YS; Kim SY; Tan W; Hwang HS; Sivasamy S; Jeong K; Kook JK; Ahn SJ; Kang IC; Ryu JH; Koh JT; Rhee JH; Lee SE
Mucosal Immunol; 2019 Mar; 12(2):565-579. PubMed ID: 30487648
[TBL] [Abstract][Full Text] [Related]
39. Fusobacterium nucleatum enhances invasion of human gingival epithelial and aortic endothelial cells by Porphyromonas gingivalis.
Saito A; Inagaki S; Kimizuka R; Okuda K; Hosaka Y; Nakagawa T; Ishihara K
FEMS Immunol Med Microbiol; 2008 Dec; 54(3):349-55. PubMed ID: 19049647
[TBL] [Abstract][Full Text] [Related]
40. HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.
González OA; Li M; Ebersole JL; Huang CB
Clin Vaccine Immunol; 2010 Sep; 17(9):1417-27. PubMed ID: 20610663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
